Immuno-Inclusivity in Opera

Part 1: Why This Matters

1.2 How to use this resource

Part 1: Why This Matters: contents
  1. 1.1 Purpose and scope
  2. 1.2 How to use this resource
  3. 1.3 What is immuno-inclusivity, and what does it have to do with opera?
  4. 1.4 Our shared and evolving hazard landscape
  5. Continued risks of COVID-19
  6. Long COVID
  7. Long COVID, opera, and performing artists
  8. 1.5 Redefining “at-risk”

Part 1 provides information about key immune-related hazards facing the Canadian opera sector.

Part 2 summarizes past and current immuno-inclusivity practices (including real-world experiences, barriers, and solutions).

Part 3 lays out Calls to Action for improving immuno-inclusivity in the Canadian opera sector, grouped by stakeholders (e.g., administrators, artists, venue managers) and settings (e.g., auditions, rehearsals, performances).

Part 4, the Toolkit, offers specific tools and techniques suited to a range of budgets, with expert guidance on implementation.

Key terms are defined in the Glossary. Find supporting resources at ImmunoInclusivityInOpera.ca

Part 1: Why This Matters: contents
  1. 1.1 Purpose and scope
  2. 1.2 How to use this resource
  3. 1.3 What is immuno-inclusivity, and what does it have to do with opera?
  4. 1.4 Our shared and evolving hazard landscape
  5. Continued risks of COVID-19
  6. Long COVID
  7. Long COVID, opera, and performing artists
  8. 1.5 Redefining “at-risk”